Health Condition 1: F102- Alcohol dependence Health Condition 2: F122- Cannabis dependence Health Condition 3: F142- Cocaine dependence Health Condition 4: F162- Hallucinogen dependence Health Condition 5: F182- Inhalant dependence Health Condition 6: F172- Nicotine dependence Health Condition 7: F112- Opioid dependence Health Condition 8: F192- Other psychoactive substance dependence Health Condition 9: F152- Other stimulant dependence Health Condition 10: F132- Sedative, hypnotic or anxiolytic
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Participants diagnosed using ICD 10 DCR 56 with Mental and Behavioural disorders due to use of alcohol dependence syndrome (F10.2), Opioid Dependence syndrome (F11.2) cannabinoids dependence syndrome (F12.2), sedatives or hypnotics, dependence syndrome. (F13.2), volatile solvents, dependence syndrome. (F18.2), multiple drug use and use of other psychoactive substances, dependence syndrome. (F19.2). 2. Participants with an overall PCL-R score of 20 and above. 3. Age range of 18-35 years of age. 4. Male Gender 5. Participants with at least a secondary level of education. 6. Participants who are fluent in Hindi or English language 7. Participants who consent to the research study
Exclusion criteria
Exclusion criteria: 1. Participants with a history of traumatic brain injury, intellectual disability or any neurological condition, organic brain disease, and epilepsy. 2. Participants with only Nicotine Dependence. 3. Participants with impairment of hearing, vision, physical or other forms of disability. 4. Participants with major functional mental illnesses (i.e., schizophrenia, schizoaffective disorder, and bipolar disorder)
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Craving, Readiness to change and Locus of controlTimepoint: Baseline, Post Intervention, and two months follow-up | — |
Primary
| Measure | Time frame |
|---|---|
| Difficulties in regulating emotions, Self-serving cognitive distortions and executive dysfunctionTimepoint: Baseline, post intervention and two months follow-up | — |
Countries
India
Contacts
Central Institute of Psychiatry